A citation-based method for searching scientific literature

Tania Aguado, Alba Huerga-Gómez, Aníbal Sánchez-de la Torre, Eva Resel, Juan Carlos Chara, Carlos Matute, Susana Mato, Ismael Galve-Roperh, Manuel Guzman, Javier Palazuelos. Br J Pharmacol 2021
Times Cited: 5







List of co-cited articles
86 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Structure of a cannabinoid receptor and functional expression of the cloned cDNA.
L A Matsuda, S J Lolait, M J Brownstein, A C Young, T I Bonner. Nature 1990
80

Δ9 -Tetrahydrocannabinol promotes oligodendrocyte development and CNS myelination in vivo.
Alba Huerga-Gómez, Tania Aguado, Aníbal Sánchez-de la Torre, Ana Bernal-Chico, Carlos Matute, Susana Mato, Manuel Guzmán, Ismael Galve-Roperh, Javier Palazuelos. Glia 2021
10
80

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors.
R Mechoulam, S Ben-Shabat, L Hanus, M Ligumsky, N E Kaminski, A R Schatz, A Gopher, S Almog, B R Martin, D R Compton. Biochem Pharmacol 1995
80

Isolation and structure of a brain constituent that binds to the cannabinoid receptor.
W A Devane, L Hanus, A Breuer, R G Pertwee, L A Stevenson, G Griffin, D Gibson, A Mandelbaum, A Etinger, R Mechoulam. Science 1992
80

2-Arachidonoylglycerol Reduces Proteoglycans and Enhances Remyelination in a Progressive Model of Demyelination.
Ana Feliú, Itziar Bonilla Del Río, Francisco Javier Carrillo-Salinas, Gloria Hernández-Torres, Leyre Mestre, Nagore Puente, Silvia Ortega-Gutiérrez, Maria L López-Rodríguez, Pedro Grandes, Miriam Mecha,[...]. J Neurosci 2017
37
80

The constitutive production of the endocannabinoid 2-arachidonoylglycerol participates in oligodendrocyte differentiation.
Oscar Gomez, Angel Arevalo-Martin, Daniel Garcia-Ovejero, Silvia Ortega-Gutierrez, Jose Antonio Cisneros, Guillermina Almazan, María Alejandra Sánchez-Rodriguez, Francisco Molina-Holgado, Eduardo Molina-Holgado. Glia 2010
60
80

Role of CB1 and CB2 receptors in the inhibitory effects of cannabinoids on lipopolysaccharide-induced nitric oxide release in astrocyte cultures.
Francisco Molina-Holgado, Eduardo Molina-Holgado, Carmen Guaza, Nancy J Rothwell. J Neurosci Res 2002
109
60

The molecular logic of endocannabinoid signalling.
Daniele Piomelli. Nat Rev Neurosci 2003
60

Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis.
Cristina Benito, Juan Pablo Romero, Rosa María Tolón, Diego Clemente, Fabián Docagne, Cecilia J Hillard, Camen Guaza, Julián Romero. J Neurosci 2007
212
60

Dose-dependent effect of cannabinoid WIN-55,212-2 on myelin repair following a demyelinating insult.
J Tomas-Roig, H Y Agbemenyah, N Celarain, E Quintana, Ll Ramió-Torrentà, U Havemann-Reinecke. Sci Rep 2020
8
60

Cannabinoid Type 2 Receptors Mediate a Cell Type-Specific Plasticity in the Hippocampus.
A Vanessa Stempel, Alexander Stumpf, Hai-Ying Zhang, Tuğba Özdoğan, Ulrike Pannasch, Anne-Kathrin Theis, David-Marian Otte, Alexandra Wojtalla, Ildikó Rácz, Alexey Ponomarenko,[...]. Neuron 2016
171
60

The endocannabinoid 2-arachidonoylglycerol regulates oligodendrocyte progenitor cell migration.
Maria A Sanchez-Rodriguez, Oscar Gomez, Pedro F Esteban, Daniel Garcia-Ovejero, Eduardo Molina-Holgado. Biochem Pharmacol 2018
16
60

Glucose metabolism links astroglial mitochondria to cannabinoid effects.
Daniel Jimenez-Blasco, Arnau Busquets-Garcia, Etienne Hebert-Chatelain, Roman Serrat, Carlos Vicente-Gutierrez, Christina Ioannidou, Paula Gómez-Sotres, Irene Lopez-Fabuel, Monica Resch-Beusher, Eva Resel,[...]. Nature 2020
73
60

A Basal Tone of 2-Arachidonoylglycerol Contributes to Early Oligodendrocyte Progenitor Proliferation by Activating Phosphatidylinositol 3-Kinase (PI3K)/AKT and the Mammalian Target of Rapamycin (MTOR) Pathways.
Oscar Gomez, Maria A Sanchez-Rodriguez, Silvia Ortega-Gutierrez, Henar Vazquez-Villa, Carmen Guaza, Francisco Molina-Holgado, Eduardo Molina-Holgado. J Neuroimmune Pharmacol 2015
30
60

Cannabinoid receptor agonists modulate oligodendrocyte differentiation by activating PI3K/Akt and the mammalian target of rapamycin (mTOR) pathways.
O Gomez, A Sanchez-Rodriguez, Mqu Le, C Sanchez-Caro, F Molina-Holgado, E Molina-Holgado. Br J Pharmacol 2011
76
60

Cannabidiol Administration Prevents Hypoxia-Ischemia-Induced Hypomyelination in Newborn Rats.
María Ceprián, Carlos Vargas, Laura García-Toscano, Federica Penna, Laura Jiménez-Sánchez, Svein Achicallende, Izaskun Elezgarai, Pedro Grandes, William Hind, M Ruth Pazos,[...]. Front Pharmacol 2019
15
60

Cannabinoids modulate Olig2 and polysialylated neural cell adhesion molecule expression in the subventricular zone of post-natal rats through cannabinoid receptor 1 and cannabinoid receptor 2.
Angel Arévalo-Martín, Daniel García-Ovejero, Ana Rubio-Araiz, Oscar Gómez, Francisco Molina-Holgado, Eduardo Molina-Holgado. Eur J Neurosci 2007
63
60

Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM.
Tobias V Lanz, R Camille Brewer, Peggy P Ho, Jae-Seung Moon, Kevin M Jude, Daniel Fernandez, Ricardo A Fernandes, Alejandro M Gomez, Gabriel-Stefan Nadj, Christopher M Bartley,[...]. Nature 2022
57
40

The Use of Cannabis and Cannabinoids in Treating Symptoms of Multiple Sclerosis: a Systematic Review of Reviews.
Suzanne Nielsen, Rada Germanos, Megan Weier, John Pollard, Louisa Degenhardt, Wayne Hall, Nicholas Buckley, Michael Farrell. Curr Neurol Neurosci Rep 2018
69
40

Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation.
Jared Ehrhart, Demian Obregon, Takashi Mori, Huayan Hou, Nan Sun, Yun Bai, Thomas Klein, Francisco Fernandez, Jun Tan, R Douglas Shytle. J Neuroinflammation 2005
265
40

Clinical response to Nabiximols correlates with the downregulation of immune pathways in multiple sclerosis.
M Sorosina, F Clarelli, L Ferrè, A M Osiceanu, N T Unal, E Mascia, V Martinelli, G Comi, F Benigni, F Esposito,[...]. Eur J Neurol 2018
9
40

Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis.
Kjetil Bjornevik, Marianna Cortese, Brian C Healy, Jens Kuhle, Michael J Mina, Yumei Leng, Stephen J Elledge, David W Niebuhr, Ann I Scher, Kassandra L Munger,[...]. Science 2022
158
40

Cannabinoids inhibit neurodegeneration in models of multiple sclerosis.
Gareth Pryce, Zubair Ahmed, Deborah J R Hankey, Samuel J Jackson, J Ludovic Croxford, Jennifer M Pocock, Catherine Ledent, Axel Petzold, Alan J Thompson, Gavin Giovannoni,[...]. Brain 2003
259
40

The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis.
Diego Centonze, Monica Bari, Silvia Rossi, Chiara Prosperetti, Roberto Furlan, Filomena Fezza, Valentina De Chiara, Luca Battistini, Giorgio Bernardi, Sergio Bernardini,[...]. Brain 2007
149
40

Advances in the Physiology of GPR55 in the Central Nervous System.
Bruno A Marichal-Cancino, Alfonso Fajardo-Valdez, Alejandra E Ruiz-Contreras, Monica Mendez-Díaz, Oscar Prospero-García. Curr Neuropharmacol 2017
52
40

2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain.
T Sugiura, S Kondo, A Sukagawa, S Nakane, A Shinoda, K Itoh, A Yamashita, K Waku. Biochem Biophys Res Commun 1995
40

The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells.
Eva Eljaschewitsch, Anke Witting, Christian Mawrin, Thomas Lee, Peter M Schmidt, Susanne Wolf, Heide Hoertnagl, Cedric S Raine, Regine Schneider-Stock, Robert Nitsch,[...]. Neuron 2006
331
40

Gene Expression Analysis of Astrocyte and Microglia Endocannabinoid Signaling during Autoimmune Demyelination.
Álvaro Moreno-García, Ana Bernal-Chico, Teresa Colomer, Alfredo Rodríguez-Antigüedad, Carlos Matute, Susana Mato. Biomolecules 2020
10
40


An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex.
Ye Zhang, Kenian Chen, Steven A Sloan, Mariko L Bennett, Anja R Scholze, Sean O'Keeffe, Hemali P Phatnani, Paolo Guarnieri, Christine Caneda, Nadine Ruderisch,[...]. J Neurosci 2014
40

2-AG limits Theiler's virus induced acute neuroinflammation by modulating microglia and promoting MDSCs.
Miriam Mecha, Ana Feliú, Isabel Machín, Cesar Cordero, Francisco Carrillo-Salinas, Leyre Mestre, Gloria Hernández-Torres, Silvia Ortega-Gutiérrez, María L López-Rodríguez, Fernando de Castro,[...]. Glia 2018
29
40


Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study.
M Herkenham, A B Lynn, M R Johnson, L S Melvin, B R de Costa, K C Rice. J Neurosci 1991
40

A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex(®) ), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis.
A Novotna, J Mares, S Ratcliffe, I Novakova, M Vachova, O Zapletalova, C Gasperini, C Pozzilli, L Cefaro, G Comi,[...]. Eur J Neurol 2011
268
40

Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli.
Katarzyna Maresz, Erica J Carrier, Eugene D Ponomarev, Cecilia J Hillard, Bonnie N Dittel. J Neurochem 2005
337
40

The endocannabinoid system and its therapeutic exploitation in multiple sclerosis: Clues for other neuroinflammatory diseases.
Valerio Chiurchiù, Mario van der Stelt, Diego Centonze, Mauro Maccarrone. Prog Neurobiol 2018
68
40

Abnormalities in the cerebrospinal fluid levels of endocannabinoids in multiple sclerosis.
M Di Filippo, L A Pini, G P Pelliccioli, P Calabresi, P Sarchielli. J Neurol Neurosurg Psychiatry 2008
54
40

Endocannabinoid signalling and the deteriorating brain.
Vincenzo Di Marzo, Nephi Stella, Andreas Zimmer. Nat Rev Neurosci 2015
215
40

Synaptic functions of endocannabinoid signaling in health and disease.
Alfonso Araque, Pablo E Castillo, Olivier J Manzoni, Raffaella Tonini. Neuropharmacology 2017
118
40

Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial.
John Zajicek, Susan Ball, David Wright, Jane Vickery, Andrew Nunn, David Miller, Mayam Gomez Cano, David McManus, Sharukh Mallik, Jeremy Hobart. Lancet Neurol 2013
84
40

Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells.
Katarzyna Maresz, Gareth Pryce, Eugene D Ponomarev, Giovanni Marsicano, J Ludovic Croxford, Leah P Shriver, Catherine Ledent, Xiaodong Cheng, Erica J Carrier, Monica K Mann,[...]. Nat Med 2007
273
40

Normal aging induces A1-like astrocyte reactivity.
Laura E Clarke, Shane A Liddelow, Chandrani Chakraborty, Alexandra E Münch, Myriam Heiman, Ben A Barres. Proc Natl Acad Sci U S A 2018
526
40

Mitochondrial CB₁ receptors regulate neuronal energy metabolism.
Giovanni Bénard, Federico Massa, Nagore Puente, Joana Lourenço, Luigi Bellocchio, Edgar Soria-Gómez, Isabel Matias, Anna Delamarre, Mathilde Metna-Laurent, Astrid Cannich,[...]. Nat Neurosci 2012
321
40

Oligodendrocyte heterogeneity in the mouse juvenile and adult central nervous system.
Sueli Marques, Amit Zeisel, Simone Codeluppi, David van Bruggen, Ana Mendanha Falcão, Lin Xiao, Huiliang Li, Martin Häring, Hannah Hochgerner, Roman A Romanov,[...]. Science 2016
463
40

Deregulation of the endocannabinoid system and therapeutic potential of ABHD6 blockade in the cuprizone model of demyelination.
Andrea Manterola, Ana Bernal-Chico, Raffaela Cipriani, Manuel Canedo-Antelo, Álvaro Moreno-García, Mar Martín-Fontecha, Fernando Pérez-Cerdá, María Victoria Sánchez-Gómez, Silvia Ortega-Gutiérrez, J Mark Brown,[...]. Biochem Pharmacol 2018
21
40

Blockade of monoacylglycerol lipase inhibits oligodendrocyte excitotoxicity and prevents demyelination in vivo.
Ana Bernal-Chico, Manuel Canedo, Andrea Manterola, María Victoria Sánchez-Gómez, Alberto Pérez-Samartín, Rafael Rodríguez-Puertas, Carlos Matute, Susana Mato. Glia 2015
59
40

Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity.
Javier Palazuelos, Tania Aguado, M Ruth Pazos, Boris Julien, Carolina Carrasco, Eva Resel, Onintza Sagredo, Cristina Benito, Julián Romero, Iñigo Azcoitia,[...]. Brain 2009
250
40

Cannabinoid CB2 receptors in the mouse brain: relevance for Alzheimer's disease.
Alicia López, Noelia Aparicio, M Ruth Pazos, M Teresa Grande, M Asunción Barreda-Manso, Irene Benito-Cuesta, Carmen Vázquez, Mario Amores, Gonzalo Ruiz-Pérez, Elena García-García,[...]. J Neuroinflammation 2018
62
40

Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain.
Tiziana Bisogno, Fiona Howell, Gareth Williams, Alberto Minassi, Maria Grazia Cascio, Alessia Ligresti, Isabel Matias, Aniello Schiano-Moriello, Praveen Paul, Emma-Jane Williams,[...]. J Cell Biol 2003
748
40


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.